Infectious disease
Influenza A PB1 591-599 (HLA-A*01:01) VSDGGPNLY
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP11319_1
Description
VSDGGPNLY is a linear peptidic epitope (epitope ID70898) studied as part of RNA-directed RNA polymerase catalytic subunit from Influenza A virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
TechData
| Sequence: | VSDGGPNLY |
| Gene: | PB1 |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | RNA-directed RNA polymerase catalytic subunit |
| UniProt Id: | P03431 |
| IEDB Id: | 70898 |
| Species: | Influenza A virus |
| Allele: | HLA-A*01:01, HLA-A1, HLA-A*29:02, HLA-A*30:02, HLA-A*80:01, HLA-B*15:01, HLA-B*15:17, HLA-B*58:01, HLA-B18, HLA-C*08:02, Mamu-A1*002:01, SLA-1*04:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Infectious disease |
| Purity: | 95% HPLC-MS |
Documents
References
Boon, A C M et al. “The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.” Journal of virology vol. 76,2 (2002): 582-90. doi:10.1128/jvi.76.2.582-590.2002